Pseudohypopyon following intravitreal triamcinolone acetonide injection.
OBJECTIVE
To report a case of a pseudohypopyon that developed after intravitreal injection of triamcinolone acetonide for choroidal neovascularization from age-related macular degeneration.


METHODS
Observational case report.


RESULTS
A 62-year-old woman received an intravitreal injection of triamcinolone acetonide for the treatment of a choroidal neovascular membrane that developed as a result of age-related macular degeneration. A layer of yellowish deposits was observed in the anterior chamber 1 day after the injection. The patient denied any pain or reduced vision, and there was no redness noted on examination. The deposits cleared spontaneously on the fourth postoperative day.


CONCLUSIONS
Pseudohypopyon may develop after intravitreal injection of triamcinolone acetonide. Distinguishing this from a true hypopyon is important because the treatment and prognosis are very different for the two conditions.
Sharma
Mithlesh C
MC
Vitreoretina Service, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago Eye and Ear Infirmary, Chicago, IL 60612, USA. sharmamc@hotmail.com
Lai
Wico W
WW
Shapiro
Michael J
MJ
D000869:Anterior Eye Segment / Q000187:drug effects* / Q000503:physiopathology; D020256:Choroidal Neovascularization / Q000188:drug therapy; D009877:Endophthalmitis / Q000139:chemically induced* / Q000503:physiopathology; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D008875:Middle Aged; D012075:Remission, Spontaneous; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014822:Vitreous Body / Q000187:drug effects*
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide